Brief: Sensei Biotherapeutics Reports Q1 2023 Financial Results And Recent Business Highlights
09/05/2023 13:33
May 9 (Reuters) - Sensei Biotherapeutics Inc SNSE.O :
* SENSEI BIOTHERAPEUTICS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* SENSEI BIOTHERAPEUTICS INC - STRONG BALANCE SHEET WITH
CASH
RUNWAY INTO SECOND HALF OF 2025
* SENSEI BIOTHERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES WERE $95.5 MILLION AS OF MARCH 31, 2023
* SENSEI BIOTHERAPEUTICS INC - QTRLY NET LOSS PER SHARE
$0.33
Source text for Eikon: ID:nGNX9w3MnL
Further company coverage: SNSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Faeth Therapeutics
See all newsU.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
Faeth Therapeutics rises after FDA grants fast-track status for cancer drug
Brief: Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial Cancer
Brief: Faeth Therapeutics Strengthens Executive Team With Senior Leadership Appointments